NCT05402644已完成不适用
Clinically Significant Portal Hypertension (CSPH) on Early-stage HCC Following Hepatectomy: What's the Impact?
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 320
- 主要终点
- death
研究概览
简要总结
Clinically significant portal hypertension (CSPH) can affect the surgical prognosis of early-stage (BCLC stage A) HCC. An additional stage, such as the BCLC stage A-B, can be considered.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HCC was diagnosed by two experienced pathologists in Child-Pugh grade A/B negative resection margin Initial diagnosis of HCC in the patients
排除标准
- •Distant transfer Not HCC
结局指标
主要结局
death
时间窗: 2009--2025
Patient survival time after surgery
recurrence
时间窗: 2009--2025
Patient recurrence time after surgery
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)Hypertension, PortalNCT03766880Nanfang Hospital, Southern Medical University175
Unknown
不适用
Portal Hypertension and Liver Resection in Patients With Hepatocellular CarcinomaPrimary Liver CancersNCT02145013Henri Mondor University Hospital200
Unknown
不适用
Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic SurgeryAdvanced Chronic Liver DiseaseSurgery--ComplicationsNCT04615091Azienda Ospedaliera Universitaria Integrata Verona250
尚未招募
不适用
Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF PatientsAcute-On-Chronic Liver FailureNCT06298656Institute of Liver and Biliary Sciences, India100
招募中
不适用
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)Portal HypertensionHepatocellular CarcinomaNCT05703750Zhongda Hospital228